Skip to Main Content
TRC_PTL_New
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Site updates: We have made updates to the logos on our site. This will not impact access to your subscription.
New! PTU Elite: Controlled Substances & Diversion prepares pharmacy technicians to manage controlled substances, covering everything from best practices for filling prescriptions to recordkeeping. Learn More.
  1. Home
  2. Browse
  3. Bone & Joint
  4. Rheumatoid Arthritis
  5. Treatment

Treatment

  • Fibromyalgia (20)
  • Fractures (5)
  • Gout (24)
  • Lupus (3)
  • Musculoskeletal (19)
  • Orthopedics (5)
  • Osteoarthritis (73)
  • Osteoporosis (165)
  • Other (19)
  • Resources (123)
  • Rheumatoid Arthritis (61)
    • Drug Toxicity (25)
    • Natural Medicines / Supplements (9)
    • Treatment (42)
      • Anti-Inflammatories (1)
16 - 30 of 42 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: Stay on Your Toes for Frequent Med Changes in Rheumatoid Arthritis June 2016
Other: Specialty Drugs: A Primer for Pharmacists and Technicians March 2016
Article: Watch for Insurance Flags or Rejects for Specialty Meds March 2016
Article: Stay Alert for Patients Taking Multiple Sources of NSAIDs September 2015
Article: Clarify Abbreviations on Methotrexate Orders October 2014
Commentary: DMARDs in the Treatment of Rheumatoid Arthritis September 2014
Article: new ORAL agent for rheumatoid arthritis, Xeljanz (ZEL-jans, tofacitinib) January 2013
Article: Rayos, a new delayed-release prednisone December 2012
Article: drug interaction alerts between methotrexate and "PPI" stomach acid reducers (omeprazole, pantoprazole, etc) December 2012
Commentary: Proton Pump Inhibitor-Methotrexate Interaction December 2012
Commentary: Rayos (Prednisone) Delayed-Release Tablets December 2012
Article: limiting NSAIDs in heart attack patients INDEFINITELY November 2012
Commentary: NSAID Use after a Heart Attack November 2012
Article: Many patients with rheumatoid arthritis will end up taking multiple meds July 2012
Guideline: 2012 Update of the 2008 American College of Rheumatology Recommendations for the Use of Disease-Modifying Antirheumatic Drugs and Biologic Agents in the Treatment of Rheumatoid Arthritis July 2012
  • « Prev
  • 1
  • 2
  • 3
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved